Our Services

Why
Samsung Biologics?

Samsung Biologics is a global biologics CDMO delivering integrated, end-to-end biologics services across research, development, and manufacturing. From organoid-based drug screening and cell line development to biologics process development, drug substance manufacturing, and aseptic fill-finish, we help biopharma companies accelerate programs with reliability, speed, and proven expertise.

Meet our experts
  • Research

    Using patient-derived organoids and 3D tumor models to support precision drug screening in early-stage research. Our organoid services help evaluate drug responses in biologically relevant oncology models.

  • Development

    Accelerating biologics development with integrated CMC development services from late discovery to clinical readiness. Our capabilities include cell line development, process development, analytical development, and clinical manufacturing support.

  • Manufacturing

    Supporting seamless scale-up with biologics manufacturing services for both clinical and commercial supply. We provide drug substance manufacturing, drug product manufacturing, and aseptic fill-finish capabilities.

  • Aseptic fill-finish

    Supporting reliable drug product delivery with integrated aseptic fill-finish services for biologics and small molecules. We provide aseptic filling, lyophilization, automated inspection, and packaging support.

Samsung Biologics is an end-to-end CDMO providing seamless solutions
from cell line development to final fill-finish, with integrated testing services across all stages.

  • 0 kL

    Total capacity

  • 0+

    Regulatory approvals

  • 0%

    Batch success rate

  • 0+

    Global clients

End-to-End Services From
Discovery to Commercialization

Contact Us

Research Services

Organoid Services for precision Drug Screening

  • Organoid Services

    Patient-derived organoids services for precision drug screening

    Learn more

Development Services

CMC Development Services from Late Discovery to Clinical Readiness

  • Late Discovery

    Lead optimization and developability assessment

    Learn more
  • Cell Line Development

    High-titer CHO cell line development and clone selection

    Learn more
  • Process Development

    Upstream/downstream process optimization and formulation design

    Learn more
  • Analytical Development

    Biologics characterization and analytical method development/validation

    Learn more
  • Non-GMP/CGMP Manufacturing

    Non-GMP and CGMP manufacturing for clinical and commercial production

    Learn more

Manufacturing Services

Biologics Manufacturing Services from Clinical to Commercial Scale

  • Drug Substance

    Clinical and commercial drug substance (DS) manufacturing

    Learn more
  • Drug Product

    Drug product (DP) manufacturing and aseptic fill-finish

    Learn more

New Modalities

ADC and mRNA Services for Advanced Modalities

  • ADC Services

    ADC conjugation and clinical/commercial manufacturing

    Learn more
  • mRNA Services

    mRNA synthesis and LNP formulation

    Learn more

Explore our full CDMO capabilities through detailed brochures.

View Brochures

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required